Standout Papers

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pool... 2018 2026 2020 2023 323
  1. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012 (2018)
    Ranee Mehra, Tanguy Y. Seiwert et al. British Journal of Cancer

Immediate Impact

2 by Nobel laureates 5 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
ATP‐Responsive Manganese‐Based Bacterial Materials Synergistically Activate the cGAS‐STING Pathway for Tumor Immunotherapy
2024 Standout
5 intermediate papers

Works of Iris Gluck being referenced

Abstract LB-339: Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC)
2018
A phase Ib study of MK-3475 in patients with human papillomavirus (HPV)-associated and non-HPV–associated head and neck (H/N) cancer.
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Iris Gluck 363 623 296 299 26 1.0k
José Rodriguez 420 633 347 208 37 1.3k
Randall P. Owen 209 391 648 195 43 1.3k
Jessica D. McDermott 501 560 551 240 40 1.3k
Parvesh Kumar 496 418 358 531 42 1.2k
Yi‐Jun Hua 486 372 377 326 34 923
Rajarsi Mandal 413 586 327 262 32 1.1k
Hao‐Yuan Mo 684 580 440 218 37 1.2k
Bryan Lin 147 293 275 169 25 981
Xin An 225 816 410 180 28 996
Laura K. Mäkinen 421 372 321 136 31 951

All Works

Loading papers...

Rankless by CCL
2026